[D-Val22] Big Endothelin-1 (16-38), human CAS NO.158884-64-1

[D-Val22] Big Endothelin-1 (16-38), human CAS NO.158884-64-1

[D-Val22] Big Endothelin-1 (16-38), human CAS NO.158884-64-1

[D-Val22] Big Endothelin-1 (16-38), human CAS NO.158884-64-1

[D-Val22] Big Endothelin-1 (16-38), human CAS NO.158884-64-1

[D-Val22] Big Endothelin-1 (16-38), human is a synthetic peptide analog derived from the Big ET-1 precursor, engineered with a D-amino acid substitution at position 22 to confer enhanced proteolytic stability. This high-purity research-grade peptide functions as a potent inhibitor of endothelin-converting enzyme (ECE), effectively blocking the maturation of Big ET-1 into active Endothelin-1. It is a critical tool for scientists investigating the endothelin system's role in cardiovascular regulation, neurovascular coupling, and hypertension pathophysiology, providing a stable and specific means to modulate this signaling axis in vitro and in vivo.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[D-Val22] Big Endothelin-1 (16-38), human 
CAS NO.
158884-64-1
Appearance
White to off-white lyophilized powder
Molecular Formula
C₁₁₉H₁₈₀N₃₂O₃₃
Molecular Weight
2685.9g/mol
Purity (RP-HPLC)
≥98% 
Solubility

Soluble in 1M acetic acid, DMSO, or deionized water

Endotoxin
≤1 EU/mg 
Biological Activity
Potent inhibitor of Endothelin Converting Enzyme (ECE); blocks ET-1 production
Storage Conditions
Store at -20°C, protected from light and moisture
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

The peptide exerts its effects by competitively inhibiting endothelin-converting enzyme (ECE), the key metalloprotease responsible for cleaving the inactive Big ET-1 precursor to produce the potent vasoconstrictor ET-1. The strategic incorporation of D-Valine at position 22 renders the peptide resistant to enzymatic degradation while maintaining high affinity for ECE. By occupying the enzyme's active site, it prevents the conversion of endogenous Big ET-1, thereby reducing the downstream activation of ETA and ETB receptors and the subsequent calcium-mediated signaling that drives vasoconstriction and smooth muscle proliferation.

upload/attachment/image/202605/07/177812465708045737c80340e0e627d82fe8354ec2_local.pngupload/attachment/image/202605/07/1778124683eb9dceec0a35002fc174a9bc034d14b3_local.png

2.PRODUCT INDICATIONS

This ECE inhibitor is indicated for preclinical research focused on conditions driven by dysregulated endothelin signaling. It is particularly suitable for studies on pulmonary arterial hypertension, chronic kidney disease, cerebral vasospasm, and heart failure models. Researchers in pharmacology and vascular biology utilize this peptide to delineate the specific contributions of ECE activity in disease progression, to develop novel therapeutic inhibitors, and to study receptor-ligand interactions in cell-based assays and animal models without the confounding effects of endogenous ET-1 generation.

upload/attachment/image/202605/07/1778124869a89643580317cb80050727f6fca19d1a_local.png

3.CLINICAL EFFICACY OF PRODUCT

While intended for research use only, [D-Val22] Big ET-1 (16-38) has demonstrated significant efficacy in preclinical models as a proof-of-concept agent. Studies have confirmed its ability to suppress ECE activity in vivo, leading to reduced levels of mature ET-1, attenuated vasoconstrictive responses, and improved hemodynamic parameters in hypertensive models. These findings underscore its utility as a robust positive control and a lead compound in the early-stage discovery of ECE-targeting therapeutics for cardiovascular and renal diseases.

upload/attachment/image/202605/07/1778124904a014c1ea4bf416421e9a8d48e4bbe436_local.png

4.Certificate

GlobalTech Co., Ltd. is committed to providing high-purity biotechnological peptide products, adhering strictly to quality standards and obtaining internationally recognized certifications.


Our production partners all employ GMP-compliant production systems and possess standardized quality control processes covering raw material procurement, synthesis, purification, testing, packaging, and storage. Each batch of product comes with complete documentation, including a Certificate of Analysis (COA), HPLC purity report, mass spectrometry (MS) chromatograms, and third-party testing reports available upon request.


We prioritize:

1.A rigorous quality management system

2.Batch traceability and stability data

3.Professional laboratory testing and validation

4.Compliance with international trade standards


Our commitment to quality, transparency, and regulatory compliance ensures the provision of reliable, stable, and research-grade peptide products to our global partners.

upload/attachment/image/202603/30/17748488791d02f82103a700e61eeafa024a96f6ff_local.jpg

5.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.

Professional and Secure Packaging

Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.

We can also customize packaging according to customer needs.

Shipping Methods 

Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

upload/attachment/image/202601/20/1768872924be74a0641f7ddbf20e541c97f2066c5c_local.jpg


Global Technology Co., Ltd. is a modern and advanced enterprise specializing in the production and export of active pharmaceutical ingredients (APIs), peptides, and plant extracts. The company invests in and collaborates closely with domestic manufacturers holding GMP, DMF, and FDA certifications, as well as laboratories at renowned universities, to meet diverse customer needs ranging from gram-level to ton-level. This enables Dejurui Pharmaceutical to provide customers with more flexible and convenient access to cost-effective, high-quality products and superior services.


We focus on the research and development and supply of high-quality chemical products, strictly adhering to international standards and quality systems. Our products are stable in performance and reliable in purity, widely used in industrial manufacturing, scientific research, and the fine chemical industry. We provide solid support at every stage with a professional and responsible attitude.


Hot Tags: DVal22BigEndothelin, #ECEInhibitor, #EndothelinResearch, #BigET1Fragment, #CardiovascularPeptide, #VasoconstrictionInhibitor, #HypertensionResearch, #ProteaseInhibitor, #EndothelinSystem, #SyntheticPeptide, #ResearchChemical, #CAS1588846461, #NeurovascularResearch, #RenalResearch

If you have any product requirements, please send an email to:support@huanqiukeji9.com;whatsapp:85244969439

Analyzing Oxandrolone Side Effects and Selective Peptides
Jun 13, 26
Analyzing Oxandrolone Side Effects and Selective Peptides
Understanding the nuances of pharmaceutical interactions and potential oxandrolone side effects is critical for researchers and clinicians aiming to optimize patient outcomes in metabolic and cardiovascular studies. While many chemical compounds offer profound therapeutic potential, the ability to distinguish between intended biological activity and adverse reactions ensures a higher standard of safety and efficacy in translational medicine. On a global scale, the demand for high-purity research peptides and active pharmaceutical ingredients has surged as scientific communities seek to mitigate the risks associated with legacy treatments.
Clinical Guide to Oxandrolone Uses and Metabolic Benefits
Jun 12, 26
Clinical Guide to Oxandrolone Uses and Metabolic Benefits
In the contemporary landscape of metabolic medicine and pharmaceutical research, understanding the diverse oxandrolone uses is pivotal for clinicians and researchers alike. While the industry continues to evolve, the demand for high-purity active pharmaceutical ingredients APIs remains the cornerstone of effective therapeutic outcomes, particularly in treating muscle wasting and metabolic dysfunction. The global shift toward personalized medicine has highlighted the importance of specific androgenic agents and GLP-1 agonists in managing complex patient profiles. By analyzing the systemic impact of these compounds, the pharmaceutical sector can better address the needs of patients recovering from severe trauma or managing chronic endocrine imbalances.
Salmon Calcitonin and oxandrolone use for Bone Health
Jun 11, 26
Salmon Calcitonin and oxandrolone use for Bone Health
The global pharmaceutical landscape is increasingly focusing on the precision of bone metabolism regulation, where the strategic oxandrolone use is often discussed in the context of anabolic recovery, yet the specialized application of Salmon Calcitonin provides a critical alternative for systemic calcium management. Understanding the nuanced differences between anabolic agents and calcitonin-based therapies is essential for healthcare providers aiming to treat severe osteoporosis and hypercalcemia. In the realm of chemical raw material manufacturing, the production of high-purity peptides like Salmon Calcitonin represents a pinnacle of biotechnological achievement. While some research focuses on oxandrolone use for muscle wasting, Salmon Calcitonin targets the osteoclast directly,

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.